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Background: Recycling of endosomes is important for trafficking and maintenance of proteins at the
neuromuscular junction (NMJ). We have previously shown high expression of the endocytic recycling regulator
Eps15 homology domain-containing (EHD)1 proteinin the Torpedo californica electric organ, a model tissue for
investigating a cholinergic synapse. In this study, we investigated the localization of EHD1 and its paralogs EHD2,
EHD3, and EHD4 in mouse skeletal muscle, and assessed the morphological changes in EHD1−/− NMJs.
Methods: Localization of the candidate NMJ protein EHD1 was assessed by confocal microscopy analysis of
whole-mount mouse skeletal muscle fibers after direct gene transfer and immunolabeling. The potential function
of EHD1 was assessed by specific force measurement and α-bungarotoxin-based endplate morphology mapping
in EHD1−/− mouse skeletal muscle.
Results: Endogenous EHD1 localized to primary synaptic clefts of murine NMJ, and this localization was confirmed
by expression of recombinant green fluorescent protein labeled-EHD1 in murine skeletal muscle in vivo.
EHD1−/− mouse skeletal muscle had normal histology and NMJ morphology, and normal specific force generation
during muscle contraction. The EHD 1–4 proteins showed differential localization in skeletal muscle: EHD2 to
muscle vasculature, EHD3 to perisynaptic regions, and EHD4 to perinuclear regions and to primary synaptic clefts,
but at lower levels than EHD1. Additionally, specific antibodies raised against mammalian EHD1-4 recognized
proteins of the expected mass in the T. californica electric organ. Finally, we found that EHD4 expression was more
abundant in EHD1−/− mouse skeletal muscle than in wild-type skeletal muscle.
Conclusion: EHD1 and EHD4 localize to the primary synaptic clefts of the NMJ. Lack of obvious defects in NMJ
structure and muscle function in EHD1−/− muscle may be due to functional compensation by other EHD paralogs.
Keywords: Neuromuscular junction, Eps homology domain containing protein, Endosomal transport, Endosomal
recycling, Bungarotoxin, Endplate, Synapse, Skeletal muscleBackground
The neuromuscular junction (NMJ) is a subcellular
specialization of the myofiber plasma membrane, with nu-
clear domains directing synaptic gene expression. Our long-
term goal is to provide a more complete molecular model of
the NMJ. We previously identified concordance of the* Correspondence: ehoffman@cnmcresearch.org
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reproduction in any medium, provided the ormammalian NMJ protein components with those of the Tor-
pedo californica electric organ, describing the developmental
origins of the organ and its extreme development into an
amplified cholinergic synapse relative to skeletal muscle, to
support its use as a model NMJ for hypothesis generation
[1]. We identified several high-abundance proteins including
Eps 15 homology domain-containing 1 (EHD1; Swiss-Prot:
Q5E9R3), adducin gamma (ADD3; Swiss-Prot:Q9UEY8),
laminin receptor protein 1 (LamR1; Swiss-Prot:Q803F6),
chromosome 1 open reading frame 123 (C1orf123; Swiss-
Prot: Q9NWV4), transgelin-3 (TAGL3; Swiss-Prot: P37805),d. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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Swiss-Prot:Q15582), which may play a role in synapse
structure and maintenance. This approach of using the
proteomic profile of an amplified model synapse should
expedite candidate NMJ protein identification and
characterization and thus help inconstructing a more
complete NMJ paradigm.
In the current study, EHD1 was examined because of
the high number of unique peptides (n = 20) identified in
the electric organ proteome relative to mouse skeletal
muscle (n = 0), and its high spectral cross-correlation
value (140). In addition, EHD1 was investigated as a per-
ipheral membrane protein that functions in clathrin-
independent endocytosis and recycling of receptors at
the membrane through the tubular endosomal recycling
compartment (ERC) [1,2].
The EHD family of proteins (EHD1 to EHD4) contain an
EH domain that facilitates interactions with proteins en-
coding asparagine-proline-phenylalanine (NPF) motifs,
which form complexes that regulate endocytic trafficking
[3,4]. The current functional paradigm for this group of
proteins is that EHD3 and EHD4 assist in the transport of
proteins from the early endosome (EE) into the ERC
whereas EHD1 and EHD2 assist in the cargo exit from the
ERC to the plasma membrane [4]. In addition to the
C-terminal EH domain that EHD proteins share with many
proteins of the endocytic machinery, EHD family proteins
share a central coiled-coil and an N-terminal phosphate
binding loop (P-loop) [3,5]. These proteins are products of
gene duplication, are encoded on separate chromosomes,
and have differential expression profiles in various tissues
[3,4,6-8]. In adult tissues, EHD1 is expressed in germ cells,
adipocytes, the eye (retina, rods and cones outer nuclear
layer, internal nuclear layer, and ganglion cell layer), the
basal membrane of the endometrium and uterine muscle
cells, granulosa cells after ovulation, skeletal muscle, kid-
ney, and spermatocytes, but it has not been found in
spleen, liver, or brain [3]. The EHD1 protein has been stud-
ied in multiple cultured cells, whole-tissue extracts, and
the testis; however, its subcellular localization in normal
tissues has not been characterized.
Several proteins known to serve as components of pre-
synaptic and postsynaptic membranes contain NPF
domains, suggesting their potential interaction with the EH
domain of EHD1 and/or other family members. At the
presynaptic membrane these include stoned (stnB),
synaptosomal-associated protein (Snap)29, secretory car-
rier membrane proteins (SCAMP)1 and SCAMP5, and
syndapin I (also known as Pacsin I). Each of these proteins
functions as part of the syanaptosome that regulates vesicle
transport and neurotransmitter release across the NMJ
[9-14]. Interestingly, the EH domain of EHD1 binds snapin,
a soluble N-ethylmaleimide-sensitive factor attachment
protein receptors (SNARE)-associated protein that doesnot contain an NPF motif, effectively blocking exocytosis
of synaptic vesicle [15]. Furthermore, neuronal-glial cell
adhesion molecule (NgCAM) trafficking is dependent on
EHD1 [16]. Overall, EHD proteins are thought to be an
important component of the presynaptic synaptosome.
In the postsynaptic membrane, ankyrins are known to
stabilize membrane and membrane-associated proteins at
the NMJ [17]. Expression of EHD1-4 proteins was
increased in ankyrin-B−/− cardiomyocytes [18]. Functional
studies in HeLa cells showed that EHD1 regulates the ex-
pression of β1 integrin via a clathrin-independent mech-
anism and Arf6 and Rab family proteins [8]. β1 integrin is
a key extracellular-matrix (ECM) receptor that facilitates
interactions with the ECM at focal adhesions but is also a
key mediator of downstream signaling pathways important
for cell survival, growth, environmental sensing, and cellu-
lar movement [19,20]. Furthermore, β1 integrin has high
expression in skeletal muscle and forms a dimer with α7
integrin at the NMJ, where it synergistically interacts with
agrin and laminins 1 and 2/4 to promote acetylcholine re-
ceptor (AChR) clustering during maturation of muscle
and AChR stability throughout life [21], supporting the
potential role of EHD1 at the NMJ.
Maintenance and signaling of postsynaptic receptors is
intimately linked to their turnover and trafficking, suggest-
ing a possible role for EHD1 and its paralogs. Both ErbB
receptor tyrosine kinases and muscle-specific tyrosine-
protein kinase receptors (MuSK) are thought to signal
after endocytosis into vesicles containing the down-
stream proteins that initiate synaptic gene transcription,
reorganization of the cytoskeletal network, and clustering
of AChRs or gene transcription (the so-called signaling
endosome hypothesis). Earlier studies showed that
ligand-induced endocytosis of MuSK occurs via a
clathrin-independent but lipid-raft-dependent pathway
[22,23]. By contrast, ErbB receptor tyrosine kinases are
internalized through the clathrin-mediated endocytic
pathway upon neuregulin binding to activate AChR ex-
pression [24]. Interestingly, the NPF-domain containing
protein phosphatidylinositol-binding clathrin assembly
protein (CALM) functions in AP-2-dependent clathrin-
mediated endocytosis [25], potentially by intersecting with
EHD proteins. Furthermore, tyrosine phosphorylation is
crucial for recycling of endocytosed AChR to the synaptic
crests; inhibitors of tyrosine phosphorylation cause AChR
to become trapped or located in perisynaptic regions [26].
Given the role of EHD1 in the transport of ligand-
bound receptors, and given the importance of ligand-
bound receptors such as MuSK and ErbB in postsynaptic
stabilization and gene expression, we hypothesized that
EHD proteins might play an important role in AChR clus-
tering and postsynaptic membrane architecture. We
report the localization and function of a previously un-
known NMJ protein, EHD1.
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Animal husbandry and care
All procedures performed on mice were approved by the
Children’s National Medical Center Institutional Animal
Care and Use Committee. Three male EHD1−/− (3, 6, and
15 months old) and three C129/C57BL/6 J (4, 6, and
15 months old) mixed background mice (kindly provided
by Dr Band, University of Nebraska Medical Center) were
used [4,7]. C57BL/6 J/J mice (The Jackson Laboratory, Bar
Harbor, MN, USA) were used for recombinant protein ex-
pression and localization studies. We used this small num-
ber of mice because of the difficulty in obtaining viable
EHD1−/− mice that survived beyond 10 postnatal days;
EHD1−/− mice survive at lower than mendelian levels be-
cause of their low mean body size, malocclusion-induced
malnutrition, and other unknown causes [7].DNA amplification and purification of candidate genes
A number of expression vector clones (pReceiver; Omic-
sLink Expression Clones; GeneCopoeia, Rockville, MD,
USA), containing the cDNA insert for NMJ proteins with
both C-terminal (M03) and N-terminal (M29) green fluor-
escent protein (GFP) sequence tag were used (GFP control
(EX-EGFP-M03), rapsyn (EX-Mm04872-M03/M29), EHD1
(EX-Mm02286-M03/M29)). Constructs were used to trans-
form Escherichia coli (GCI-5α™ Chemically Competent
E. coli Gene Copoeia™) in accordance with the company’s
guidelines (Transformation Protocol for cDNA Clones from
Filter Paper Discs). The transformed E. coli were grown
overnight at 37°C with continuous shaking at 250 rpm in
Luria broth with ampicillin 100 μg/ml (Sigma, St. Louis,
MO, USA) added for selection of transformed cells. Plas-
mids were purified using a commercial kit (PureLink™
HiPure Plasmid Midiprep Kit; Invitrogen, Carlsbad, CA,
USA) in accordance with the manufacturer’s directions. All
purified plasmids were reconstituted in sterile phosphate-
buffered saline (PBS) and measured on a spectrophotom-
eter (ND 1000; Thermo Scientific, Wilmington, DE, USA)
for approximating purity and concentration (OD A260/
A280 >1.8). Purified plasmids were stored at 4°C or at
−20°C depending on the time of use.Intramuscular injection of naked DNA into mouse tibialis
anterior muscle
C57Bl/6 J mice (6 to 10 weeks old were anesthetized with
1–3% isofluorane/O2. Their hind legs were shaved and
then wiped with 70% isopropyl alcohol. Five injections
(5 μl each) of a plasmid suspension in sterile PBS (1 μg/μl)
were given intramuscularly into the tibialis anterior (TA)
muscle using a 26 gauge needle (RN NDL 26/20/2 s) and a
25 μl syringe (802RN 22 s/2’/2) (both Hamilton Reno, NV,
USA). At 3 or 14 days after the injection, the mice were
killed using carbon dioxide and cervical dislocation.Immunofluorescent microscopy of whole-mount isolated
muscle fibers for Green fluorescent protein localization
The mouse TA muscle was fixed in situ with 2% parafor-
maldehyde in PBS at the time of dissection, and stored
overnight in 10% sucrose/PBS at 4°C as previously
described [27]. The TA muscle was manually teased apart
into small fiber bundles and incubated in blocking and
permeabilization buffer (PBS containing 0.5% TritonX-100,
0.1% Tween 20, 2% bovine serum albumin (BSA) and 20%
horse serum) overnight at 4°C. Fibers were incubated with
anti-GFP rabbit IgG fraction Alexa Fluor 555 conjugate
(Invitrogen) 1:400 dilution in antibody buffer (PBS contain-
ing 0.2% TritonX-100, 0.1% Tween 20, 2% BSA in PBS) for
2 hours with gentle mixing. Fibers were separated by centri-
fugation at 4000 g for 1 minute, then washed with 0.1%
Tween-20 in PBS, repeating this cycle three times. Fibers
were counterstained with α-bungarotoxin (BTX) Alexa
Fluor 488 conjugate (Invitrogen) 1:3000 in PBS for 10 min
to label NMJs, then washed three times, counterstained
with 40,6-diamidino-2-phenylindole (DAPI, dilactate; Invi-
trogen) 1:5000 in double-distilled H2O to label nuclei, and
finally washed three more times. Fibers were left in wash
buffer overnight at 4°C with gentle mixing, then mounted
(Fluoromount-G; Southern Biotech, Birmingham, AL,
USA). Confocal laser-scanning microscopy was performed
using a laser-scanning microscope (LSM 510) coupled to
microscopy software (Zen LE) (both Carl Zeiss, Jena,
Germany). Qualitative analysis of recombinant protein
localization was assessed relative to BTX labeling of NMJs.Immunofluorescent microscopy of whole-mount isolated
muscle fibers for Eps15 homology domain-containing
protein localization and neuromuscular junction
morphological mapping
Fibers from EHD1−/− and C129/C57BL/6 J mice were
prepared for confocal microscopy as described above, ex-
cept for the use of the following EHD antibodies, previ-
ously generated and described [4]. Fibers were labeled
with 1:200 rabbit anti-EHD1, EHD2, EHD3, and EHD4
antibodies and 1:500 Alexa Fluor 555 F(ab')2 fragment of
goat anti-rabbit IgG (H+L; Invitrogen). Peripheral
nerves were labeled with 1:500 neuronal class III
β-tubulinmonoclonal antibody (TUJ1;Covance,Princeton,
NJ, USA) and 1:250 Alexa Fluor 568 goat anti-mouse IgG
(H+L) secondary antibody (Invitrogen). Fibers that were
only counterstained with BTX Alexa Fluor 555 conjugate
(Invitrogen) 1:3000 in PBS and with DAPI (Invitrogen)
1:5000 in double-distilled H2O were not incubated in the
blocking and permeablization buffer, but were placed in
PBS for immediate counterstaining and mounting as
described above. Qualitative analysis of immunolabeled
protein localization was assessed relative to BTX labeling
of NMJs.
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domain-containing protein proteins to investigate
conservation across species
The gastrocnemius muscles were dissected and flash frozen
in liquid nitrogen. Muscle was ground in a mortar and pes-
tle set in a dry ice bath, cooled with liquid nitrogen, and
homogenized using a hand homogenizer in lysis buffer
(0.25 mol/l sucrose, 20 mmol/l Tris pH 8.0, 25 mmol/l KCl,
5 mmol/l MgCl2, and protease inhibitor (Mini Complete
Protease Inhibitor; Roche Diagnostics, Basel, Switzerland).
The homogenates were left on ice for 30 minutes, and were
then sonicated on ice for 30 pulses (50% duty cycle, pulsed-
hold, output control limit 3; Sonifier Cell Distributer 350;
Branson Scientific, Danbury, CT USA), followed by an add-
itional 30 minutes on ice, after which homogenates were
separated by centrifugation at 10,000 g for 15 minutes at
4°C. for each homogenate, the supernatant was collected
and the pellet was suspended in EBC buffer (50 mmol/l
Tris–HCl pH 8.0, 120 mmol/l NaCl, 1% Triton-X 100, and
protease inhibitor (as before; Roche). All lysates were
desalted by passing the sample through a BioSpin6 micro
column before protein quantification (DC Protein Assay;
BioRad, Hercules, CA, USA). The protein extracts were
stored at 80°C until electrophoresis. For each lysates, 20 μg
of protein was loaded onto a one-dimensional SDS-PAGE
gel (Novex NuPage 4–12% Bis-Tris MiniGel Systems; Invi-
trogen) in 2-(N morpholino) ethanesulfonic acid (MES)
buffer (Invitrogen) at room temperature or 3-(N-morpho-
lino)propanesulfonic acid (MOPS)buffer at 4°C, then trans-
ferred to nitrocellulose membrane (Amersham Hybond
ECL; GE Healthcare, Piscataway, NJ, USA) at a constant
current of 0.02 amps overnight at 4°C in transfer buffer
(NuPage Transfer Buffer (Invitrogen, Carlsbad, CA, USA)
in accordance with manufacturer’s directions. Blots were
rinsed in TBS-T buffer (Tris–HCl pH 7.5 (Invitrogen,
Carlsbad, CA) plus 0.1% Tween20 (Sigma)), blocked in 5%
blotting grade milk (BioRad) in TBS-T for 1 hour at room
temperature, then probed with rabbit anti-EHD1-4 anti-
bodies overnight at 4°C/ EHD1 and EHD4 were co blotted
because of the cross reactivity of the EHD1 antibody. Blots
were rinsed several times in TBS-T buffer, probed with
1:2000 goat anti-rabbit IgG H+L HRP secondary antibody
(Invitrogen) for 1 hour at room temperature, rinsed again,
developed using a commercial kit (Amersham ECL Kit), and
exposed to film (Amersham HyperFilm ECL) (both GE
Healthcare). Blots were then stripped (0.35 ml of 100 mmol/l
2-mercaptoethanol and 2% SDS in 10 ml of 62.5 mmol/l
Tris–HCl pH 6.8, 3.125 ml of 62.5 mmol/l Tris–HCl pH
6.8, made up to 50 ml with distilled water) for 1 hour at
50°C, rinsed, blocked, and reprobed for GAPDH (14 C10;
rabbit monoclonal antibody diluted 1:4000 in TBS-T with
3% BSA in TBST; #2118, Cell Signaling, Danvers, MA,
USA) using the same secondary antibody as stated above.
Soluble and insoluble extracts of T. californica were resolvedby SDS-PAGE and transferred to nitrocellulose membrane
to blot for EHD1-4 proteins as described above,except that
in this case we used MOPS running buffer, 1:20,000 goat
anti-rabbit IgG H+L HRP secondary antibody, and a differ-
ent substrate (SuperSignal West Pico Chemiluminescent
Substrate‘ Thermo Scientific, Rockford, IL. USA). We per-
formed a qualitative analysis of EHD1-4 protein expression
in wild-type (WT) and EHD1−/− mouse skeletal muscle and
T. californica electric organ fractions.
Muscle dissection for in vitro force measurements
Mice were anesthetized with intraperitoneal injections of
ketamine 70 mg/kg and xylazine 7 mg/kg. Supplemental
doses were administered as needed to maintain adequate
levels of anesthesia throughout the dissection of the mus-
cles. Experiments were conducted on the Extensor digi-
torum longus (EDL) and soleus muscle of the right hind
limb from control (n=3) and EHD1 null (n=3) mice. The
EDL muscle was isolated and 6–0 silk sutures were tied se-
curely to the distal and proximal tendon. The muscle was
then removed from the mouse and placed in a vertical bath
containing buffered mammalian Ringer solution (37 mmol/
l NaCl, 24 mmol/l NaHCO3, 11 mmol/l glucose, 5 mmol/l
KCl, 2 mmol/l CaCl2, 1 mmol/l MgSO4, 1 mmol/l
NaH2PO4, and 0.025 mmol/l turbocurarine chloride, pH
7.4 at 25°C, and bubbled with 95% O2/5% CO2. The distal
tendon of the muscle was tied securely to the lever arm of
a servomotor/force transducer (model 305B; Aurora Scien-
tific, Richmond Hill, ON, Canada) and the proximal tendon
to a fixed clamp. After performing a protocol of force con-
tractions, the same dissection procedure was used for the
soleus muscle. After removal of the soleus muscle, animals
were killed with an overdose of CO2.
Measurement of contractile properties in vitro
Muscles were stimulated between two platinum electro-
des. Using supramaximal stimulation of the muscle with
single 0.2-ms square stimulation pulses, muscle length
was adjusted to the length (Lo) that resulted in maximal
twitch force. With the EDL muscle held at Lo0, the
muscle was stimulated for 300 ms with increasing stimu-
lation frequencies of 30, 50, 80, 100, 120, 150, 180, 200,
220 and 250 Hz to establish the plateau of force gener-
ation (maximum isometric tetanic force, Po). Each
stimulus was separated by 2 minutes of rest. A similar
protocol was applied to the soleus muscle, but the
stimulation frequencies were 30, 50, 80 and 100 Hz and
the stimulus duration was 1000 ms. The muscle length
was then measured with calipers, and after removal of
the muscle from the bath, the mass of the muscle was
determined. The optimum fiber length (Lf ) was calcu-
lated by multiplying Lo by a previously determined Lf/Lo
ratio of 0.45 for the EDL muscle and by 0.71 for the soleus
muscle [28]. Total muscle fiber cross-sectional area was
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and the density of mammalian skeletal muscle (1.06 mg/
mm3). Maximum isometric specific force (sPo) was deter-
mined by dividing Po by the total muscle fiber cross-
sectional area.
Statistical analysis
Student’s t-test was used to compare the sPo means of
WTand EHD1−/− skeletal muscle, with P<0.05 considered
significant we performed stats in Excell with the Data
Analysis add-in. We performed F-tests followed by t-tests,
which are described in the Results section with the data.
Results
Eps15 homology domain-containing 1 protein localizes to
the primary synaptic cleft in skeletal muscle
Our proteomic data identified EHD1 as an abundant pro-





















Figure 1 Recombinant green fluorescent protein (GFP)-tagged Eps15
neuromuscular junction (NMJ). Control and EHD1 proteins were expressed
skeletal muscle as C-terminal and N-terminal GFP recombinant proteins. Four m
was fixed in situ and teased into small bundles for immunofluorescence and vi
labeling of AChRs at the NMJ. Expression of GFP (vector) was seen as a diffuse
(n= 7). Rapsyn-GFP expression localized exclusively to the NMJ of transfected f
bottom left panel. N- and C-terminal GFP recombinant EHD1 proteins localized
of transfection (n= 24). Each image consists of separate blue (DAPI), green (BTX
channels in addition to a merged image. Scale bars: 20 μm. The larger referenc
images. It reflects the 20 μm scale bar that was added within the Zen softwaremammalian EHD1 might be an uncharacterized candidate
neuromuscular junction protein. To investigate the expres-
sion and localization profile of EHD1, the complete murine
cDNA was cloned into M03 and M29 vectors (GeneCo-
poeia) for expression of EHD1 with N- or C-terminal GFP
tags, respectively, under control of a cytomegalovirus
(CMV) immediate-early promoter (EX-Mm02286-M03/
M29). For each recombinant protein expressed, 25 g of
purified DNA in PBS was injected directly into the TA
muscle of four WTC57BL/6 J)mice as fiveinjections of 5
μleach to transfect a subset of myofibers. Skeletal muscle
autofluoresces near the same wavelength as GFP, thus to
reduce this innate background signal, anti-GFP Alexa 555
was used to detect recombinant protein expression. Mor-
phological mapping of NMJs was carried out by labeling
AChRs at the postsynaptic membrane with BTX Alexa 488
conjugate. The high density of these receptors generated
an intense signal that delineates the primary synaptic cleftEHD1 C-GFP
EHD1 C-GFP
homology domain-containing (EHD) protein localizes to the
for 3 or 14 days in 6- to 10-week-old C57Bl/6 J mouse tibialis anterior (TA)
ice were injected for each recombinant protein expressed. The TA muscle
sualization via confocal microscopy, referenced to α-bungarotoxin (BTX)
signal throughout the myofiber and did not concentrate at the NMJ
ibers (n=2). Both transfected and non-transfected fibers are shown in the
to the NMJ and to the primary synaptic cleft with BTX after 3 or 14 days
Alexa Fluor 488 conjugate), and red (anti-GFP Alexa Fluor 555 conjugate)
e bar was added in powerpoint to make the 20 μm bar visible in the
upon image acquisition.
Figure 2 Eps15 homology domain-containing (EHD)1 is
expressed in mouse skeletal muscle and localizes to the
primary synaptic clefts of neuromuscular junctions. (A) Western
blot of two WT and two EHD1−/− skeletal muscle lysates probed with
peptide-specific antibodies against EHD1 and EHD4 showedexpression
in skeletal muscle and verified the loss of EHD1 in null mice.
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) served as a
loading control. (B)The tibialis anterior (TA) skeletal muscles of three
wild-type (WT) and three EHD1−/− mice were teased into small bundles
for immunofluorescence and visualization via confocal microscopy. α-
bungarotoxin (BTX) labeling of AChRs denote NMJs in all images. EHD1
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relative to this NMJ marker using confocal microscopy.
To demonstrate the properties of CMV promoter-
driven recombinant protein expression in mouse skeletal
muscle with subsequent localization analysis by confocal
microscopy, GFP and rapsyn were expressed in vivo for
3 days to serve as controls. Expression of GFP, a non-
muscle protein, was seen as a diffuse and non-specific
























localized to the NMJ and delineated the primary synaptic cleft similar
to BTX labeling. (C) Because the EHD1 antibody crossreacts with EHD4,
imparting low background signal, EHD1−/− fibers were labeled with
anti-EHD1 to show the specificity of the localization. Blue, DAPI; green,
BTXAlexa Fluor 488 conjugate; red, anti-green fluorescent protein Alexa
Fluor 555 conjugate. Scale bars: 20 μm. A larger reference bar was
added above the scale bars.aggregation of signal at the NMJ (Figure 1). Rapsyn, a
protein located exclusively at the NMJ, localized specific-
ally to the synapse without any detectable signal in
extrasynaptic regions (Figure 1). Together, these controls
support the use of the CMV promoter-driven recombinant
gene expression of candidates from direct DNA injection
for localization analyses. EHD1 N-terminal and C-terminal
GFP-tagged recombinants expressed for 3 or 14 days all
showed localization at the synapse (Figure 1). Diffuse
immunostaining of EHD1 was seen in other areas of the
myofiber, although at a lower intensity than in the NMJ.
To confirm and extend the EHD1-GFP fusion loca-
lization data, TA muscles were fixed in situ and teased
apart into small myofiber bundles for immunofluorescence
and confocal microscopy analysis using antibodies gener-
ated against EHD1 peptides. Characterization of EHD1 and
EHD4 antibodies identified crossreactivity of EHD1 anti-
body with EHD4 protein, but not the reverse [4]. Western
blotting of skeletal muscle lysates with EHD1 and EHD4
antibodies showed that each antibody was able to identify
these two paralogs and identify their expression in skeletal
muscle (Figure 2A). Myofiber bundles were isolated from
the TA muscle of three 129/C57 BL6 mixed background
(WT) and three EHD1−/− mice for immunolocalization
analysis by confocal microscopy [7]. Myofibers were coun-
terstained with α-BTXAlexa 488 conjugate to denote the
primary synaptic cleft of NMJs by labeling the AChRs, and
with DAPI to stain nuclei. WT myofibers showed strong
colocalization of EHD1 with α-BTXat the NMJ, and this
signal was lost in the EHD1−/− NMJs (Figure 2B,C). This
confirmed the fusion protein data showing preferential
localization of EHD1 at the myofiber NMJ.Eps15 homology domain-containingproteins 1–4 show
differential localization in skeletal muscle
The T. californica proteomic data identified peptides that
were shared between EHD paralogs and peptides unique
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studies in WT and EHD1−/− muscle to EHD2, EHD3, and
EHD4 using anti-peptide antibodies specific for their cor-
responding paralog [4]. Using the same isolated myofiber
method for immunostaining, the TA muscle from three
mice per group was analyzed. EHD2 signal was consis-
tent with expression in muscle vasculature, suggesting
localization in endothelial cells (Figure 3A). There was no
evidence of immunostaining for EHD2 in the NMJ. The
EHD3 signal was concentrated at the postsynaptic mem-
brane but did not delineate the primary synaptic cleft as
EHD1 did; instead, EHD3 localized to perisynaptic areas,
the area adjacent to BTX-labeled NMJs, and to the vascu-
lature, although to a lesser extent than EHD2 (Figure 3B).














Figure 3 Eps15 homology domain-containing (EHD) 1–4 proteins sho
(TA) skeletal muscles of three wild-type (WT) and three EHD1−/− mice were
via confocal microscopy. α-bungarotoxin (BTX) labeling of AChRs denote n
expressed in WT and EHD1−/− mice. Panel (A) EHD2 localized to skeletal m
adjacent to theBTX labeling and in the vasculature, but to a lesser extent th
to adjacent extrasynaptic regions and perinuclear regions. (D) EHD 1–4 exp
EHD1-4 antibodies also recognized proteins of similar mass in Torpedo calif
conjugate; red, anti-rabbit Alexa Fluor 555 conjugate.Scale bars: 20 μm. A laperinuclear regions to a greater extent than other family
members, but had weaker staining of the primary synaptic
cleft at lower levels than EHD1 (Figure 3C). Antibody la-
beling of EHD2 to EHD4 proteins in EHD1−/− fibers
showd similar staining patterns to those found in WT
fibers (Figure 3).
Expression of EHD1 gene transcripts in WT and
EHD1−/− skeletal muscle was confirmed by reverse tran-
scriptase PCR (data not shown), verifying the lack of
EHD1expression in EHD1−/− mouse skeletal muscle [4].
Western blotting further validated the expression of
EHD1 to EHD4 proteins in WT skeletal muscle and of
all but EHD1 in EHD1−/−skeletal muscle (Figure 3D).
Furthermore, western blotting using the same anti-
















































w differential localization in skeletal muscle. The tibialis anterior
teased into small bundles for immunofluorescence and visualization
euromuscular junctions (NMJs) in all images. EHD2, 3, and 4 are
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an EHD2. (C) EHD4 localized to the synaptic cleft with BTX in addition
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Figure 4 Eps15 homology domain-containing (EHD)4
expression is increased in EHD1−/− muscle. The tibialis anterior
(TA) skeletal muscle of three wild-type (WT) and three EHD1−/− mice
were teased into small bundles for immunofluorescence labeling
with anti-EHD4 antibody and z-stacks were acquired to assess signal
throughout the entire myofiber diameter/thickness via confocal
microscopy. α-bungarotoxin (BTX) labeling of AChRs denote NMJs.
EHD4 signal intensities were compared in myofibers (n = 5) and at
neuromuscular junctions (NMJs) (n = 10) from WT and EHD1−/− mice
(n = 3 per group) using identical acquisition parameters. (A) The z-
section with the highest signal for EHD4 (red channel). (B) Intensity
projections of the EHD4 signal from representative NMJs in (A). Blue,
DAPI; green, BTX Alexa Fluor 488 conjugate; red, anti-rabbit Alexa
Fluor 555 conjugate.Scale bars: 20 μm. A larger reference bar was
added above the scale bars. (C) The average intensity of EHD4
expressed in WT and EHD1−/− mice. The bars represent the average
vector measurements of the intensity with standard error from
myofibers and NMJs in each group. Statistical significance was
measured by Student’s t-test (P< 0.05).
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organ with similar molecular weights to those of mam-
malian EHD proteins, suggesting a high degree of cross-
species conservation (Figure 3E). With the exception of
the two peptides that are unique to EHD1, all other pep-
tides found in the electric organ proteome that were
mapped to EHD1 were shared by EHD3.
Eps15 homology domain-containing (EHD)4 shows
increased expression and enrichment at the
neuromuscular junction in EHD1−/− myofibers
The signal intensity of EHD4 in EHD1−/− mouse myofibers
appeared to be greater than that in WT myofibers. Con-
focal z-stacks of WT and EHD1−/− myofibers, dissected
from three mice per group labeled with EHD4 antibody,
were acquired under identical parameters (40× objective,
1 μm z-section interval, mean of four images, 1 AU pinhole
(blue 9.9; green4.7; red 13.4), 720 gain on the blue channel,
725 gain on the green channel, and 531 gain on the red
channel) to assess signal intensity levels. Representative
WT and EHD1−/− NMJs in EHD4 labeled myofibers
(Figure 4) show the z-slice with greatest signal intensity
was on the red channel. Intensity projections of the z-slice
(Figure 4A) reinforced the abundant signal of EHD4 in
EHD1−/− myofibers, showing the previously described
localization at the NMJ and at perinuclear regions in both
WT and EHD1−/− skeletal muscle (Figure 4B). However,
the amplification of EHD4 expression in EHD1−/− muscle
was enriched throughout the length of the myofibers.
Quantification of signal intensities throughout the entire
myofiber, not specifically localized to the NMJ, were esti-
mated using vector intensity measurements applied by the
Zen software. Measurements were performed on represen-
tative fibers (n= 5), analyzed per animal (n=3) per group
(n=2). The mean intensity per group was assessed for sig-
nificance using a one-tailed Student’s t-test assuming un-
equal variance, which was determined using the F-test,
with P<0.05. EHD4 signal intensity levels were signifi-
cantly greater in EHD1−/− myofibers (Figure 4C). Further-
more, we assessed the intensity of EHD4 at NMJs in
representative fibers (n=10) from each mouse (n= 3) per
group (n=2) using the same method. EHD4 signal inten-
sity levels were also significantly greater at the NMJ of
EHD1−/− myofibers (one-tailed Student’s t-test assuming
unequal variance, which was determined using the F-test,
with P<0.05; Figure 4C).
Neuromuscular junction morphology is generally
maintained in Eps15 homology domain-containing
(EHD)1−/− skeletal muscle
The high specificity of α-BTX for AChR at the NMJ syn-
aptic crests permitted us to study the synaptic endplate
structure with fluorescence confocal microscopy. Mor-
phological mapping of NMJs in TA skeletal muscle fibersof 3-, 6-, and 15-month-old EHD1−/− mice showed that
most endplates had morphology similar to the NMJs of 4-,
6-, and 15-month-old WT mice (Figure 5). For morpho-
logical assessment of endplate structure, 260 WT and 275
EHD1−/− NMJs were analyzed. Furthermore, NMJs in WT
and EHD1−/− mice did not differ in size; the length of 68
NMJs per group had equal variance, determined using the
F-test, and no significant difference in mean size was seen
(Student’s t-test, P< 0.05; data not shown).
EHD1-/- 
WT 
Figure 5 Neuromuscular junctions (NMJs) in Eps15 homology domain-containing (EHD)1−/− mice show no morphological defects in
synaptic endplate structure. (A) The tibialis anterior (TA) skeletal muscle fibers from three EHD1−/− and three wild-type (WT) mice were labeled
with α-bungarotoxin (BTX) Alexa Fluor 555 or 488 conjugate for morphological mapping of endplates using confocal microscopy. NMJs were
seen in both WT (n = 260) and in EHD1−/− (n = 275) fibers. Blue, DAPI; green, BTX Alexa Fluor 488 conjugate; red, anti-rabbit Alexa Fluor 555
conjugate. Scale bars: 20 μm. A larger reference bar was added above the scale bars.
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synaptic structure in EHD1−/− skeletal muscle. The char-
acteristic ‘pretzel-like’ morphology of the WT endplates
was discontinuous, forming two discrete endplates, with
regions showing little architecture (Figure 6A). This
morphology cannot be explained by age-dependent end-
plate fragmentation, because the primary clefts remained
continuous and were not separated into the small
‘islands’ typically seen at 18 months of age, when signifi-
cant number of fibers show age-specific alterations [29].
Furthermore, we did not find near these partitioned end-
plates any centrally located nuclei that would indicate an
injury-induced regenerated endplate from that formed
during development. This may indicate incomplete
pruning, axon sprouting from a single motor neuron
that has two distinct terminal endings, or altered AChR
trafficking or clustering beneath these endplates.
To study the number of nerve termini innervating
NMJs, motor axons were immunolabeled for confocal mi-
croscopy analysis using an antibody specific for the neuro-
filament TUJ1. The TA muscles from three mice per
group were used for the analysis of partitioned endplates;13 partitioned NMJs were seen in WT muscle and 12 in
EHD1−/− muscle. WT and EHD1−/− endplates were singly
innervated, even when the endplate was partitioned
(Figure 6B). Because WT fibers also displayed partitioned
endplates, it is unlikely that the partitioning represented
an aberrant structure or resulted from the loss of function
of EHD1.
Eps15 homology domain-containing (EHD)1−/− mouse
skeletal muscle does not show pathology or a reduction in
contractile force compared with wild-type skeletal muscle
Because EHD1−/− skeletal muscle showed no overt synap-
tic defects, we assessed the overall muscle structure using
hematoxylin and eosin (H&E) staining and assessed
muscle function by measuring the intrinsic capacity to
generate force during a muscle contraction. H&E-stained
cross-sections of TA muscle (8 μm; n=3 per group) were
devoid of invading white blood cells, hypotropic and
hypertrophic fibers, and regenerated fibers with centrally
located nuclei (Figure 7A). Furthermore, there was no def-
icit in specific force generation in EHD1−/−compared with







Figure 6 Neuromuscular junctions (NMJs) of Eps15 homology domain-containing (EHD)1−/− mice are innervated by a single motor
axon. Panel (A) Isolated tibialis anterior (TA) skeletal muscle fibers from three EHD1−/− and three wild-type (WT) mice were labeled with (BTX)
Alexa Fluor 555 conjugate for morphological mapping of endplates using confocal microscopy. Rare EHD1−/−endplates (n = 2) consisted of two
discreet structures, with one being smaller and less developed than the other. (B) Isolated TA skeletal muscle fibers from three EHD1−/− and three
WT mice were immunolabeled with neuronal class III β-tubulin monoclonal antibody (TUJ1) antibody, a neuronal marker, and visualized using
confocal microscopy. WT (n = 13) and EHD1−/− (n = 12) endplates with partitioning were seen. EHD1−/− endplates were singly innervated, even
when partitioned. Blue, DAPI; green, α-BTXAlexa Fluor 488 conjugate; red, anti-mouse Alexa Fluor 568 conjugate. Scale bars: 20 μm. A larger
reference bar was added above the scale bars.
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from three EHD1−/− mice showed no deficit compared
withthe EDL (241± 37 kN/m2) and soleus (231± 2 kN/m2)
muscle of the three WT mice (Figure 7B). All force mea-
surements were normalized to muscle cross-sectional
area. H&E staining of the EDL and soleus cross-sections
had normal histology as previously described in the TA
skeletal muscles, which is consistent with normal skeletal
muscle function (data not shown). Indirectly, the mainten-
ance of contractile force further supports healthy muscle
structure and function in the absence of EHD1.Discussion
In this study, we characterized EHD1 and its family mem-
bers through morphological mapping using in vivo recom-
binant gene expression in WT and EHD1−/− mice. We
found localization of EHD1 at the NMJ primary clefts of
mouse TA skeletal muscle in addition to extrasynaptic
regions of myofibers at lower levels. Furthermore, EHD1
−/− muscle fibers had normal NMJ morphology, histology,
and function despite the deficient mice having a lower
body mass and size. Muscle-wide expression of EHD1 was




EDL Muscle Soleus Muscle
Figure 7 Eps15 homology domain-containing (EHD)1−/− skeletal muscle shows normal pathology and generates average specific force.
Panel (A) Stainnig of tibialis anterior (TA) skeletal muscle cryosections (8 μm) from three WT and three EHD1−/− mice did not show no
degeneration or regeneration of fibers in EHD1−/− mice, as shown by the absence of centralized nuclei. There was an absence of infiltrating white
blood cells, also suggesting normal pathology (hematoxylin and eosin). (B) The force generated during a muscle contraction was measured
in vivo in three WT and three EHD1−/− EDL and soleus muscles each. EHD1−/− EDL and soleus muscles showed no deficit in the amount of force
generated during a muscle contraction (n = 3 per group).
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areas of rat TA skeletal muscle.
Transmission electron microscopy studies show an
abundance of vacuoles in the space between secondary
clefts at the NMJ [31], presumably to assist in receptor-
mediated endocytosis and receptor recycling at the mem-
brane. It seems that EHD family members localize to these
vacuoles; based on the localization profiles in this study,
EHD1, EHD3, and EHD4 are more likely than EHD2 to
localize to these structures. Future studies using ultrastruc-
tural analyses and immunolocalization of EHD proteins
should help to address this prediction. A functional role of
EHD1 at the NMJ would suggest that loss of EHD1 should
result in decreased receptor recycling at the membrane,
forcing the formation of alternate endplates from newly
synthesized receptors and the loss of proteins that interact
with the extracellular matrix. The lack of morphological
changes in EHD1−/− endplates is therefore striking. Based
on our earlier work with EHD4 in ear and testis and EHD3
in renal glomerular endothelial cells [32-34], the lack of an
apparent phenotypic abnormality associated with lack of
EHD1 at the NMJ could be explained by compensation by
other paralogs, most likely EHD3 and EHD4, given their
high similarity in protein sequence, domain structure, and
localization. Our quantitative analyses of EHD4 expressionin EHD1−/− versus WT mice support this view (Figure 4).
The loss of RME-1 (EHD1) in Caenorhabtidis elegans
results in the accumulation of large vesicles in the intes-
tines, suggesting a trafficking defect [4]. This defect was
rescued by the expression of each one of the human EHD
proteins, suggesting a conserved and redundant role of
these paralogs. EHD3 has the greatest sequence similarity
and overlaps in function with EHD1 during endosomal
transport, and double knockdown of EHD1 and EHD4 in
HeLa cells resulted in aberrant distribution of endocytic
protein complexes [35]. Furthermore, EHD3 directly inter-
acts with ankyrin B (ankyrin 2) [18]. Ankyrin-2 L and G
are both localized to the troughs of synaptic folds, and
NMJ morphology is altered in ankyrin-2 L−/− skeletal
muscle [36,37]. We hypothesize that double-knockout
mouse models of EHD1 with either EHD3 or 4 may result
in aberrant NMJ morphology.
NMJ morphology may not be indicative of function, for
several reasons. First, the level of AChRs at the endplate
exceeds the minimum concentration required to reach the
action potential threshold. Second, the development of
primary cleft arborization occurs within the first postnatal
week, which is well after the motor neuron makes contact
with the muscle fiber [38]. However, arborized endplates
are not a requirement to invoke an action potential, as
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to determine if endplates of double-knockout mouse mod-
els show aberrant morphology, and if the skeletal muscle
shows sign of muscle weakness, which would indicate
impaired synaptic transmission and support our hypoth-
esis that the lack of observed defects in EHD1−/− skeletal
muscle is the result of compensation by other members. If
this proves to be true, these double-mutant mice may be
useful to further study receptor recycling and turnover,
and to test the ‘signaling endosome’ hypothesis of tyrosine
kinase receptors at the NMJ.
Conclusions
In this study, we characterized the localization and func-
tion of a previously unknown NMJ protein. EHD1 is a
NMJ protein that localized to the primary synaptic cleft.
EHD1−/− mouse skeletal muscle shows no functional def-
icit or endplate structural defects. Furthermore, this study
provides experimental support for the hypothesis that
paralogs of this family are compensatory in function.
EHD4 also localized to the primary synaptic cleft, and was
increased in EHD1−/− mouse skeletal muscle, suggesting a
compensatory function for this family member.
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